Grupo Cooperativo de Hemopatías Malignas Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Huixquilucan Mexico

Organization Overview

First Clinical Trial
2018
NCT03755947
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Grupo Cooperativo de Hemopatías Malignas